Diagnosis and management of multiple myeloma: a review

AJ Cowan, DJ Green, M Kwok, S Lee, DG Coffey… - Jama, 2022 - jamanetwork.com
Importance Multiple myeloma is a hematologic malignancy characterized by presence of
abnormal clonal plasma cells in the bone marrow, with potential for uncontrolled growth …

Bone metastases

RE Coleman, J Brown, I Holen - Abeloff's clinical oncology, 2020 - Elsevier
Bone metastasis is a major cause of morbidity in persons with cancer. Complications include
pain, impaired mobility, pathological fracture, spinal cord compression, cranial nerve …

[HTML][HTML] Bone health in cancer patients: ESMO Clinical Practice Guidelines

R Coleman, JJ Body, M Aapro, P Hadji, J Herrstedt… - Annals of oncology, 2014 - Elsevier
There are three distinct areas of cancer management that make bone health in cancer
patients of increasing clinical importance. First, bone metastases are common in many solid …

[HTML][HTML] European Myeloma Network guidelines for the management of multiple myeloma-related complications

E Terpos, M Kleber, M Engelhardt, S Zweegman… - …, 2015 - ncbi.nlm.nih.gov
Abstract The European Myeloma Network provides recommendations for the management
of the most common complications of multiple myeloma. Whole body low-dose computed …

[HTML][HTML] Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients

V Shah, AL Sherborne, BA Walker, DC Johnson… - Leukemia, 2018 - nature.com
Robust establishment of survival in multiple myeloma (MM) and its relationship to recurrent
genetic aberrations is required as outcomes are variable despite apparent similar staging …

International Myeloma Working Group recommendations for the treatment of multiple myeloma–related bone disease

E Terpos, G Morgan, MA Dimopoulos… - Journal of clinical …, 2013 - ascopubs.org
Purpose The aim of the International Myeloma Working Group was to develop practice
recommendations for the management of multiple myeloma (MM)–related bone disease …

International Myeloma Working Group consensus statement for the management, treatment, and supportive care of patients with myeloma not eligible for standard …

A Palumbo, SV Rajkumar, JF San Miguel… - Journal of clinical …, 2014 - ascopubs.org
Purpose To provide an update on recent advances in the management of patients with
multiple myeloma who are not eligible for autologous stem-cell transplantation. Methods A …

The bone-marrow niche in MDS and MGUS: implications for AML and MM

IM Ghobrial, A Detappe, KC Anderson… - Nature reviews Clinical …, 2018 - nature.com
Several haematological malignancies, including multiple myeloma (MM) and acute myeloid
leukaemia (AML), have well-defined precursor states that precede the development of overt …

Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma

MM McDonald, MR Reagan, SE Youlten… - Blood, The Journal …, 2017 - ashpublications.org
Multiple myeloma (MM) is a plasma cell cancer that develops in the skeleton causing
profound bone destruction and fractures. The bone disease is mediated by increased …

Myeloma bone disease: from biology findings to treatment approaches

E Terpos, I Ntanasis-Stathopoulos… - Blood, The Journal of …, 2019 - ashpublications.org
Bone disease is a cardinal complication of multiple myeloma that affects quality of life and
survival. Osteocytes have emerged as key players in the development of myeloma-related …